Broker tips: Tate&Lyle, RBS, 888 Holdings
16th Feb 2015 15:21
Tate & Lyle is looking sweet, analysts at Cannacord Genuity said in a research note e-mailed to clients on Monday. The company is expected to benefit from multiple tailwinds. Together with a now substantially greater possibility of a take-over attempt - given its current valuation - by US rival Bung
Read moreFTSE 250 movers: Afren hit by rescue deal talks, Hunting rises on upgrade
16th Feb 2015 14:11
Afren came top of the fallers as the company revealed it was in rescue deal discussions with bondholders and other lenders after last week's announcement that talks for a combination with Seplat Petroleum had been terminated. The company said it was continuing discussions with the advisers to its la
Read moreUS rival Bunge may be developing a taste for Tate & Lyle
16th Feb 2015 13:47
Tate & Lyle is looking sweet, analysts at Cannacord Genuity said in a research note e-mailed to clients on Monday. The company is expected to benefit from multiple tailwinds. Together with a now substantially greater possibility of a take-over attempt - given its current valuation - by US rival Bung
Read moreSector movers: Food stocks binned after Tate & Lyle profit warning
6th Feb 2015 14:49
Tate & Lyle was dampening the food sector in London on Friday after the sweeteners maker disappointed investors with its second profit warning in just four months. Tate & Lyle said it now expects adjusted pre-tax profits for the year ending 31 March to be below previous guidance of £230m-245m. The
Read moreTate & Lyle plummets as US sweetener weakness prompts profits warning
6th Feb 2015 07:42
Sweeteners maker Tate & Lyle, famous for making Splenda sucralose, disappointed investors on Friday with a profit warning on the back of weakness in the bulk ingredients division, which accounts for around two-thirds of sales. The performance of bulk ingredients in Tate & Lyle's third quarter ended
Read moreDirector deals: Chairmen of BATM and Dods splash the cash
6th Jan 2015 15:49
The chairs of two companies splashed the cash on Tuesday to show their belief in improving fortunes at both outfits. Gideon Chitayat, chairman of BATM Advanced Communications, a provider of telecoms and medical technology, dug deep into his pockets to spend £217,000 worth of shares. Chitayat, a ser
Read moreMonday broker round-up UPDATE
17th Nov 2014 10:32
African Barrick Gold: Investec reduces target price from 262p to 170p and downgrades to sell. Associated British Foods: Liberum initiates with a target price of 3470p and a buy recommendation. Bodycote: Investec lowers target price from 750p to 745p and maintains its buy recommendation. Centamin:
Read moreFriday broker round-up UPDATE
7th Nov 2014 09:44
AstraZeneca: Deutsche Bank increases target price from 4100p to 4350p and reiterates its hold recommendation. AVEVA: Societe Generale reduces target price from 2250p to 2000p, while keeping its buy recommendation. Big Yellow Group: Citi raises target price from 470p to 540p and maintains its neutra
Read moreFriday tips round-up: Tate & Lyle, AstraZeneca
7th Nov 2014 08:44
Tate & Lyle has had a very difficult year with the two profit warnings. The reasons behind the downgrades are varied, ranging from cold weather in the US to a fire at the Singapore factory where its sweetener Sucralose is manufactured. In aggregate all of those negatives knocked £41m out of the comp
Read moreTate & Lyle's first half profits fall as sales hit by lower prices
6th Nov 2014 09:03
Tate & Lyle's profits slumped in the first half as sales were hurt by operational disruption and competition for its Splenda Sucralose product. The agribusiness reported a 40% drop in adjusted pre-tax profit to £104m as sales declined 21% to £1.38bn. The company said sales were dragged down by lowe
Read moreWednesday broker round-up UPDATE
24th Sep 2014 09:15
Aggreko: Morgan Stanley ups target price from 1350p to 1375p, while leaving its underweight rating unaltered. Alliance Pharma: Canaccord Genuity lowers target price from 35p to 33p reiterating its hold recommendation. Close Brothers Group: UBS moves target price from 1420p to 1430p and keeps a neut
Read moreFTSE 250 movers: Tate & Lyle slides after profit warning
23rd Sep 2014 14:55
Sweetener maker Tate & Lyle led the downside after issuing a profit warning. It blamed severe US weather and the temporary shutdown of a plant in Singapore for higher costs, but did also say that sales of its flagship Splenda sucralose sweetener were ahead of last year. It admitted that the first ha
Read moreLondon midday: Stocks drop as US Treasury acts to block tax inversion deals
23rd Sep 2014 12:38
UK stocks were firmly lower come midday, tracking overnight losses on Wall Street, with investors apparently reacting the US Treasury's move last night to make corporate tax inversions more difficult. Acting as a backdrop, traders were monitoring the first coalition airstrikes against Islamic State
Read moreLondon pre-open: FTSE to edge lower ahead of Eurozone PMIs
23rd Sep 2014 07:42
UK-listed stocks were forecast to register a small decline at Tuesday's opening bell, extending losses seen both at home and abroad the previous day. City sources predict the FTSE 100 will open around four points higher than yesterday's close of 6,773.63. CMC market analyst Jasper Lawler said: "Eur
Read moreTate & Lyle warns on profits after bad US weather
23rd Sep 2014 07:37
Sweetener maker Tate & Lyle blamed severe US weather and the temporary shutdown of a plant in Singapore for higher costs and a profit warning, although it said sales of its flagship Splenda sucralose sweetener were ahead of last year. Tate & Lyle said the first half of the year had been very challen
Read more